Answers are grounded in this paper and cite their sources.
This comparative effectiveness research study examines outcomes associated with pembrolizumab and nivolumab among US veterans with advanced, unresectable, or metastatic melanoma.
No takes yet. Share an insight, caveat, or question.
Strohbehn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: